ClinicalTrials.Veeva

Menu

Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair

H

Hadassah Medical Center

Status

Unknown

Conditions

Tracheo Esophageal Fistula

Treatments

Procedure: Endoscopic repair of recurrent TEF by trichloroacetic acid aplications

Study type

Interventional

Funder types

Other

Identifiers

NCT01287312
shlomoco-HMO-CTIL

Details and patient eligibility

About

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.

The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Full description

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.

We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Enrollment

20 estimated patients

Sex

All

Ages

1 month to 20 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • children age 1 month- 20 years old with recurrent TEF.
  • Failure of surgical repair.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

shlomo cohen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems